Stock Performance and Market Context
The stock has been on a steep decline, losing 65.81% over the past 21 consecutive trading sessions. This sharp fall contrasts starkly with the broader market, where the Sensex, despite a recent loss of 5.93% over the last three weeks, managed to gain 0.44% today, supported by mega-cap stocks. Trident Texofab’s underperformance is further highlighted by its 1-year return of -68.46%, compared to the Sensex’s positive 5.09% over the same period.
Today, the stock underperformed its sector by 5.79%, opening at Rs.55.2 and touching the intraday low at the same price, indicating a lack of upward momentum. It currently trades below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a bearish technical setup. This persistent weakness is underscored by technical indicators such as the MACD and Bollinger Bands, which remain bearish on weekly and monthly charts, while the RSI shows mixed signals with weekly bullishness but no monthly confirmation.
Financial Metrics and Fundamental Assessment
Trident Texofab’s financial profile reveals several areas of concern. The company reported its lowest quarterly net sales at Rs.25.74 crores in the December 2025 quarter, reflecting subdued revenue generation. Its long-term fundamental strength remains weak, with an average Return on Capital Employed (ROCE) of 6.88%, which is modest for the industry. Additionally, the company’s ability to service debt is limited, as indicated by a high Debt to EBITDA ratio of 6.83 times, suggesting elevated leverage and potential financial strain.
Despite these challenges, the company’s valuation metrics present a somewhat contrasting picture. With a ROCE of 7.4 and an Enterprise Value to Capital Employed ratio of 1.3, the stock is trading at a discount relative to its peers’ historical valuations. Furthermore, the company’s profits have increased by 122.5% over the past year, even as the stock price declined sharply, resulting in a PEG ratio of 0.5. This divergence between profit growth and stock performance highlights the complex dynamics influencing investor sentiment.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Shareholding and Sectoral Position
The majority of Trident Texofab’s shares are held by non-institutional investors, which may contribute to the stock’s volatility and price sensitivity. Operating within the Garments & Apparels sector, the company faces competitive pressures and sectoral headwinds that have influenced its recent performance. The stock’s 52-week high was Rs.379, underscoring the magnitude of the decline to the current low of Rs.55.2.
Technical Summary and Market Sentiment
Technical analysis paints a predominantly cautious picture. Daily moving averages are bearish, and weekly indicators such as the KST and Dow Theory also signal mild to strong bearishness. The monthly outlook remains mildly bearish, with no clear bullish reversal signals. The stock’s Relative Strength Index (RSI) on a weekly basis shows some bullish tendencies, but this has not translated into price recovery. The absence of significant volume support, as indicated by On-Balance Volume (OBV) data, further emphasises the subdued market interest.
In the broader market, the Sensex experienced a volatile session, initially opening 809.57 points higher before retreating by 470.26 points to close at 77,905.47. The index remains below its 50-day moving average, although the 50DMA itself is above the 200DMA, suggesting mixed medium-term momentum. Mega-cap stocks led the market gains, contrasting with the performance of mid and small caps such as Trident Texofab.
Holding Trident Texofab Ltd from Garments & Apparels? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Long-Term Performance and Market Positioning
Over the last three years, Trident Texofab has consistently underperformed the BSE500 index, reflecting persistent challenges in both near-term and long-term performance metrics. The stock’s Mojo Score currently stands at 23.0, with a Mojo Grade of Strong Sell, upgraded from Sell on 3 February 2026. This grading reflects the company’s weak fundamental strength and market positioning.
Market capitalisation grading is low at 4, indicating limited scale relative to peers. The stock’s valuation discount relative to peers is notable, but this has not translated into price support amid ongoing market pressures. The company’s profit growth of 122.5% over the past year contrasts with the stock’s price decline, suggesting that earnings improvements have yet to be fully recognised by the market.
Summary of Key Metrics
To summarise, Trident Texofab Ltd’s stock has reached a new 52-week low of Rs.55.2 after a sustained period of decline. The stock’s technical indicators remain bearish, and it trades below all major moving averages. Financially, the company faces challenges with modest ROCE and high leverage, despite recent profit growth and attractive valuation metrics. The stock’s underperformance relative to the Sensex and sector peers highlights the difficulties faced in regaining investor confidence.
Market conditions remain volatile, with the broader index showing mixed signals. Trident Texofab’s position within the Garments & Apparels sector and its shareholding structure contribute to its current market dynamics. The stock’s recent downgrade to a Strong Sell grade by MarketsMOJO reflects these factors comprehensively.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
